p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy

Figure 1 Cumulative survival curve of 36 patients. A significant difference that was not found was observed between the survival rates of the patients with p53-negative and p53-positive expression.

Figure 2 Relation between survival rates of 36 patients and staging of esophageal cancer. No significant difference was seen between survival curves of the p53-negative and p53-positive patients and esophageal cancer staging.